The biology of CCR5 and CXCR4

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Current Opinion in HIV and AIDS

• Publication date

  2009-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/COH.0b013e328324bbecPMID 19339947PMCID PMC2718543
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chemokines and their receptors: drug targets in immunity and inflammation.

  2008cited by this paper
• G protein-coupled receptor sorting to endosomes and lysosomes.

  2008cited by this paper
• Biphasic decay kinetics suggest progressive slowing in turnover of latently HIV-1 infected cells during antiretroviral therapy

  2008cited by this paper
• The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist

  2008cited by this paper
• A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor.

  2008cited by this paper
• Chemokine Signaling Controls Endodermal Migration During Zebrafish Gastrulation

  2008cited by this paper
• Resistance to human immunodeficiency virus type 1 (HIV-1) generated by lentivirus vector-mediated delivery of the CCR5{Delta}32 gene despite detectable expression of the HIV-1 co-receptors.

  2008cited by this paper
• CCR5Delta32 59537-G/A promoter polymorphism is associated with low translational efficiency and the loss of CCR5Delta32 protective effects.

  2008cited by this paper
• CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from West Nile virus encephalitis

  2008cited by this paper
• G-protein coupled receptor structure.

  2007cited by this paper
• CCR5Δ32 59537-G/A Promoter Polymorphism Is Associated with Low Translational Efficiency and the Loss of CCR5Δ32 Protective Effects

  2007cited by this paper
• A Naturally Occurring Splice Variant of CXCL12/Stromal Cell-Derived Factor 1 Is a Potent Human Immunodeficiency Virus Type 1 Inhibitor with Weak Chemotaxis and Cell Survival Activities

  2007cited by this paper
• Identification of a Postendocytic Sorting Sequence in CCR5

  2007cited by this paper
• Chemokine: receptor structure, interactions, and antagonism.

  2007cited by this paper
• CCR5Δ32 Protein Expression and Stability Are Critical for Resistance to Human Immunodeficiency Virus Type 1 In Vivo

  2007cited by this paper
• Dichotomous effects of C-C chemokines in HIV-1 pathogenesis.

  2007cited by this paper
• HIV coreceptors: from discovery and designation to new paradigms and promise.

  2007cited by this paper
• I want a new drug: G-protein-coupled receptors in drug development.

  2006cited by this paper
• Biology of CCR5 and its role in HIV infection and treatment.

  2006cited by this paper
• CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment.

  2006cited by this paper
• Identification and expression of novel isoforms of human stromal cell-derived factor 1.

  2006cited by this paper
• Anti-HIV therapy: Current and future directions.

  2006cited by this paper
• Structure of an unliganded simian immunodeficiency virus gp120 core

  2005cited by this paper
• Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity

  2005cited by this paper
• Pathogenesis of macrophage tropic HIV-1.

  2005cited by this paper
• Role for CCR5Δ32 Protein in Resistance to R5, R5X4, and X4 Human Immunodeficiency Virus Type 1 in Primary CD4+ Cells

  2004cited by this paper
• Coevolution of RANTES Sensitivity and Mode of CCR5 Receptor Use by Human Immunodeficiency Virus Type 1 of the R5 Phenotype

  2004cited by this paper
• The CCR5 and CXCR4 Coreceptors—Central to Understanding the Transmission and Pathogenesis of Human Immunodeficiency Virus Type 1 Infection

  2004cited by this paper
• An absence of CCR5 on donor cells results in acceleration of acute graft-vs-host disease.

  2004cited by this paper
• Persistence of dual-tropic HIV-1 in an individual homozygous for the CCR5Δ32 allele

  2002cited by this paper
• Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor

  2002cited by this paper
• A Human Immunodeficiency Virus Type 1 Isolate from an Infected Person Homozygous for CCR5Δ32 Exhibits Dual Tropism by Infecting Macrophages and MT2 Cells via CXCR4

  2002cited by this paper
• HIV-1 infection in individuals with the CCR5-Delta32/Delta32 genotype: acquisition of syncytium-inducing virus at seroconversion.

  2002cited by this paper
• HIV-1 Infection in Individuals With the CCR5-Δ32/Δ32 Genotype: Acquisition of Syncytium-Inducing Virus at Seroconversion

  2002cited by this paper
• Persistence of dual-tropic HIV-1 in an individual homozygous for the CCR5 Delta 32 allele.

  2002cited by this paper
• Mechanisms of viral membrane fusion and its inhibition.

  2001cited by this paper
• An overview of the determinants of CCR5 and CXCR4 co-receptor function.

  2001cited by this paper
• Analysis of chemokine receptor endocytosis and recycling.

  2000cited by this paper
• Crystal structure of rhodopsin: A G protein-coupled receptor.

  2000cited by this paper
• The effect of genetic variation in chemokines and their receptorson HIV transmission and progression to AIDS

  2000cited by this paper
• Sequential CD4-Coreceptor Interactions in Human Immunodeficiency Virus Type 1 Env Function: Soluble CD4 Activates Env for Coreceptor-Dependent Fusion and Reveals Blocking Activities of Antibodies against Cryptic Conserved Epitopes on gp120

  2000cited by this paper
• CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist.

  1999cited by this paper
• An HIV-1-infected individual homozygous for the CCR-5 delta32 allele and the SDF-1 3'A allele.

  1999cited by this paper
• Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5 delta32.

  1998cited by this paper
• The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens.

  1998cited by this paper
• Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

  1998cited by this paper
• Human Immunodeficiency Virus (HIV) Envelope Binds to CXCR4 Independently of CD4, and Binding Can Be Enhanced by Interaction with Soluble CD4 or by HIV Envelope Deglycosylation

  1998cited by this paper
• The antigenic structure of the HIV gp120 envelope glycoprotein

  1998cited by this paper
• The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract

  1998cited by this paper
• Patterns of CCR5, CXCR4, and CCR3 Usage by Envelope Glycoproteins from Human Immunodeficiency Virus Type 1 Primary Isolates

  1998cited by this paper
• Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor.

  1998cited by this paper
• Exclusive and Persistent Use of the Entry Coreceptor CXCR4 by Human Immunodeficiency Virus Type 1 from a Subject Homozygous for CCR5 Δ32

  1998cited by this paper
• HIV-1 infection in an individual homozygous for CCR5▵32

  1997cited by this paper
• Atomic structure of the ectodomain from HIV-1 gp41

  1997cited by this paper
• Core structure of gp41 from the HIV envelope glycoprotein.

  1997cited by this paper
• HIV-1 infection in a man homozygous for CCR5 delta 32.

  1997cited by this paper
• Phorbol Esters and SDF-1 Induce Rapid Endocytosis and Down Modulation of the Chemokine Receptor CXCR4

  1997cited by this paper
• HIV Coreceptor Downregulation as Antiviral Principle: SDF-1α–dependent Internalization of the Chemokine Receptor CXCR4 Contributes to Inhibition of HIV Replication

  1997cited by this paper
• HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: independence from G protein signaling and importance of coreceptor downmodulation.

  1997cited by this paper
• Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient.

  1997cited by this paper
• HIV-1 infection in an individual homozygous for the CCR5 deletion allele

  1997cited by this paper
• HIV-1 infection in an individual homozygous for CCR5 delta 32. Seroco Study Group.

  1997cited by this paper
• HIV-1 infection in a man homozygous for CCR5▵32

  1997cited by this paper
• Homozygous Δ32 deletion of the CCR‐5 chemokine receptor gene in an HIV‐1‐infected patient

  1997cited by this paper
• Evidence for Cell-Surface Association Between Fusin and the CD4-gp120 Complex in Human Cell Lines

  1996cited by this paper
• Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP‐1α, MIP‐1β, and RANTES

  1996cited by this paper
• CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1.

  1996cited by this paper
• The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

  1996cited by this paper
• The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

  1996cited by this paper
• CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5

  1996cited by this paper
• A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors.

  1996cited by this paper
• CC CKR5: A RANTES, MIP-1α, MIP-1ॆ Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1

  1996cited by this paper
• The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

  1996cited by this paper
• HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

  1996cited by this paper
• Identification of a major co-receptor for primary isolates of HIV-1

  1996cited by this paper
• CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5

  1996cited by this paper
• Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1

  1996cited by this paper
• Molecular cloning and functional expression of a new human CC-chemokine receptor gene.

  1996cited by this paper
• HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

  1996cited by this paper
• Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes.

  1994cited by this paper
• A proposed bovine neuropeptide Y (NPY) receptor cDNA clone, or its human homologue, confers neither NPY binding sites nor NPY responsiveness on transfected cells.

  1993cited by this paper
• Molecular cloning of cDNAs encoding a LD78 receptor and putative leukocyte chemotactic peptide receptors.

  1993cited by this paper
• Molecular cloning, characterization, and localization of the human homolog to the reported bovine NPY Y3 receptor: lack of NPY binding and activation.

  1993cited by this paper
• Molecular cloning of the cDNA and chromosomal localization of the gene for a putative seven-transmembrane segment (7-TMS) receptor isolated from human spleen.

  1993cited by this paper
• Crystal structure of an HIV-binding recombinant fragment of human CD4

  1990cited by this paper
• Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains

  1990cited by this paper
• Crystal structure of an HIV-binding recombinant fragment of human CD4.

  1990cited by this paper

• JAK-STAT and IL-17 pathway dysregulation underlies persistent immune dysfunction in ART-experienced people living with HIV in Ghana.

  2026cites this paper
• Roles of Reactive Oxygen Species in Relationships Between Viral Infections and Alzheimer’s Disease and Related Dementia

  2026cites this paper
• SSB‐2548 Inhibits CXCR‐4 Activation, Inducing Apoptosis in Acute Myeloid Leukemia Cells

  2025cites this paper
• A high-resolution analysis of arrestin2 interactions responsible for CCR5 endocytosis

  2025cites this paper
• Hormonology: A kaleidoscopic tale of dedication, serendipity, and ingenuity.

  2025cites this paper
• Insights on the role of the chemokine CCL8 in pathology.

  2025cites this paper
• Revolutionizing drug delivery: The promise of surface functionalized dendrimers in overcoming conventional limitations

  2025cites this paper
• Frequency of the CCR5Δ32 Variant in Haematopoietic Progenitor Cell Donors From Argentina: Implications for Transplantation in HIV‐1 Infected Patients

  2025cites this paper
• HIV-1 Entry Mechanisms: Protein-Host Receptor Interactions and Membrane Fusion Dynamics.

  2025cites this paper
• TRAIL (DR5) receptor and the modulation of TRAIL pathway in PLWHIV: key mechanisms in the progression of HIV disease

  2025cites this paper
• HIV vaccination: Navigating the path to a transformative breakthrough—A review of current evidence

  2024cites this paper
• Lectibodies as antivirals.

  2024cites this paper
• A Review of FDA-Approved Anti-HIV-1 Drugs, Anti-Gag Compounds, and Potential Strategies for HIV-1 Eradication

  2024cites this paper
• The Role of Peptides in Combatting HIV Infection: Applications and Insights

  2024cites this paper
• Hybrid Virtual Screening Approach to Predict Novel Natural Compounds against HIV-1 CCR5.

  2024cites this paper
• CRISPR-Cas based genome editing for eradication of human viruses.

  2024cites this paper
• Pro-inflammatory macrophages suppress HIV replication in humanized mice and ex vivo co-cultures

  2024cites this paper
• Unraveling clinical outcomes of long-term cART treatment in HIV-1 patients with or without the Brazilian GWGR motif in the V3 loop

  2024cites this paper
• Development of a Sensitive Anti-Mouse CCR5 Monoclonal Antibody for Flow Cytometry

  2024cites this paper
• Development of Sensitive Anti-Mouse CCR5 Monoclonal Antibodies Using the N-Terminal Peptide Immunization

  2024cites this paper
• CCR5Δ32 and HLA allele diversity in bone marrow donors from southern Brazil

  2024cites this paper
• HIV-Associated Neurocognitive Disorder (HAND) and Alzheimer’s Disease Pathogenesis: Future Directions for Diagnosis and Treatment

  2024cites this paper
• Prevalence of HPV in anal cancer: exploring the role of infection and inflammation

  2024cites this paper
• C-X-C motif chemokine ligand 12—C-X-C chemokine receptor type 4 signaling axis in cancer and the development of chemotherapeutic molecules

  2024cites this paper
• The Chemistry of Creating Chemically Programmed Antibodies (cPAbs): Site-Specific Bioconjugation of Small Molecules.

  2023cites this paper
• CXCR4-Targeted Radiopharmaceuticals for the Imaging and Therapy of Malignant Tumors

  2023cites this paper
• Structural dynamics of chemokine receptors.

  2023cites this paper
• Host Genetic Impact on Infectious Diseases among Different Ethnic Groups

  2023cites this paper
• MECHANISMS OF EVACUATION OF THE HUMAN PAPILLOMA VIRUS FROM THE IMMUNE RESPONSE IN HIV-INFECTED PEOPLE

  2023cites this paper
• Resistance to HIV-1 Infection Conferred by a Compound CCR5Δ32 and CCR5 C20S Heterozygote.

  2023cites this paper
• Using molecular dynamics simulations to show differences of movement over time in the CCR5 variants of genetically edited children

  2023cites this paper
• Structural basis of dimerization of chemokine receptors CCR5 and CXCR4

  2023cites this paper
• A key GPCR phosphorylation motif discovered in arrestin2⋅CCR5 phosphopeptide complexes.

  2023cites this paper
• Oncogenic Proteomics Approaches for Translational Research and HIV-Associated Malignancy Mechanisms

  2023cites this paper
• HIV-1 release requires Nef-induced caspase activation

  2023cites this paper
• Engineered Human Antibody with Improved Endothelin Receptor Type A Binding Affinity, Developability, and Serum Persistence Exhibits Excellent Antitumor Potency.

  2022cites this paper
• The Role of Inflammation in Anal Cancer

  2022cites this paper
• Opening the door on entry inhibitors in HIV: Redefining the use of entry inhibitors in heavily treatment experienced and treatment‐limited individuals living with HIV

  2022influential citation
• Transcriptome-wide association study of HIV-1 acquisition identifies HERC1 as a susceptibility gene

  2022cites this paper
• Preparation of a stable CCL5·CCR5·Gi signaling complex for Cryo-EM analysis.

  2022cites this paper
• A NanoBiT assay to monitor membrane proteins trafficking for drug discovery and drug development

  2022cites this paper
• Association of chemokine (CXC motif) receptor 4 expression with lymphovascular invasion and lymph node metastasis of invasive breast cancer

  2022cites this paper
• Establishment of Novel Anti-Mouse CCR3 Monoclonal Antibodies (C3Mab-6 and C3Mab-7) by N-terminal Peptide Immunization

  2022cites this paper
• Synthetic gRNA/Cas9 Ribonucleoprotein Inhibits HIV Reactivation and Replication

  2022cites this paper
• C–C chemokine receptor 5 and acute graft‐versus‐host disease

  2022influential citation
• Lipid Raft Facilitated Receptor Organization and Signaling: A Functional Rheostat in Embryonic Development, Stem Cell Biology and Cancer

  2022cites this paper
• Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy

  2022cites this paper
• Promising Marine Natural Products for Tackling Viral Outbreaks: A Focus on Possible Targets and Structure-Activity Relationship.

  2022cites this paper
• Pharmacophore-Oriented Identification of Potential Leads as CCR5 Inhibitors to Block HIV Cellular Entry

  2022cites this paper
• Synthesis and Anti-HIV Activity of a Novel Series of Isoquinoline-Based CXCR4 Antagonists

  2021influential citation
• HIV/AIDS: Current Updates on the Disease, Treatment and Prevention

  2021influential citation
• Stem Cell Therapy and Its Significance in HIV Infection

  2021cites this paper
• Biocomputational Screening and Pharmacological Studies of Gymnema sylvester in Contrast to Human CCR5 and CXCR4 Chemokine Receptors

  2021cites this paper
• Biased action of the CXCR4-targeting drug plerixafor is essential for its superior hematopoietic stem cell mobilization

  2021cites this paper
• PET Imaging Radiotracers of Chemokine Receptors

  2021cites this paper
• Mechanisms of Proteinuria in HIV

  2021cites this paper
• The impact of intradialytic exercise on immune cells expressing CCR5+ in patients with chronic kidney disease: A cross-over trial

  2021influential citation
• Cryo-EM structures of HIV-1 trimer bound to CD4-mimetics BNM-III-170 and M48U1 adopt a CD4-bound open conformation

  2021cites this paper
• Biased action of the CXCR4-targeting drug plerixafor is essential for its superior hematopoietic stem cell mobilization

  2021cites this paper
• Human Immunodeficiency Virus Infection Promotes Human Papillomavirus-Mediated Anal Squamous Carcinogenesis: An Immunologic and Pathobiologic Review

  2021cites this paper
• How Antibodies Recognize Pathogenic Viruses: Structural Correlates of Antibody Neutralization of HIV-1, SARS-CoV-2, and Zika

  2021cites this paper
• The Role of L-Selectin in HIV Infection

  2021cites this paper
• Clinical parameters and selected HLA and chemokine gene variants associated with late presentation into care of people living with HIV/AIDS.

  2021cites this paper
• Chimeric antigen receptor T-cell therapy for HIV cure

  2021cites this paper
• Chemokine receptor 5 blockade modulates macrophage trafficking in renal ischaemic‐reperfusion injury

  2020cites this paper
• CCR5-Δ32 gene variant frequency in the Turkish Cypriot population

  2020cites this paper
• Cryo-EM Structures of HIV-1 trimer bound to CD4-mimetics M48U1 and BNM-III-170 adopt a CD4-bound open conformation

  2020cites this paper
• CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future

  2020cites this paper
• Genetically-edited iPSCs derived from HIV-1 infected patients on therapy can give rise to immune cells resistant to HIV-1 infection.

  2020cites this paper
• Single High-Dose Radiation Enhances Dendritic Cell Homing and T Cell Priming by Promoting Reactive Oxygen Species-Induced Cytoskeletal Reorganization.

  2020cites this paper
• The Impact of Cellular Proliferation on the HIV-1 Reservoir

  2020cites this paper
• Structural basis of the activation of the CC chemokine receptor 5 by a chemokine agonist

  2020cites this paper
• Emerging therapeutic roles of exosomes in HIV-1 infection

  2020cites this paper
• Functional impact of HIV-1 Tat on cells of the CNS and its role in HAND

  2020cites this paper
• Beyond HIV infection: Neglected and varied impacts of CCR5 and CCR5Δ32 on viral diseases

  2020cites this paper
• HIV: Can gene editing provide a cure for HIV?

  2020cites this paper
• Multifaceted ammonia transporters

  2020cites this paper
• Ex vivo cell-based CRISPR/Cas9 genome editing for therapeutic applications.

  2020cites this paper
• The G protein coupled receptor CXCR4 designed by the QTY code becomes more hydrophilic and retains cell signaling activity

  2020cites this paper
• Genetic variation in the chemokine receptor 5 gene and course of HIV infection; review on genetics and immunological aspect

  2020cites this paper
• HIV X4 Variants Increase Arachidonate 5-Lipoxygenase in the Pulmonary Microenvironment and are associated with Pulmonary Arterial Hypertension

  2020cites this paper
• The Role of the CXCL12/CXCR4/ACKR3 Axis in Autoimmune Diseases

  2019cites this paper
• Prevalence and risk factors of virologic failure and HIV-1 drug resistance among children and adolescents in Nairobi, Kenya

  2019influential citation
• Assessment of Expression of Phosphorylated CXCR4 in AML Blast cells and Its Relation to the Disease Prognosis

  2019cites this paper
• Innate lymphoid-macrophage crosstalk promotes lung cancer regression in response to IL-12 therapy

  2019cites this paper
• The endometrial immune environment of women with endometriosis.

  2019cites this paper
• CCR5 status and metastatic progression in colorectal cancer

  2019cites this paper
• Novel Antiretroviral Structures from Marine Organisms

  2019cites this paper
• In-vitro Assays for Determining Anti-HIV Potential of Phytochemicals

  2019cites this paper
• Entanglement of CCR5 and Alzheimer’s Disease

  2019cites this paper
• Pleiotropic Roles of Cytokines in HIV-1 Pathogenesis and Control: A Literature Review

  2019cites this paper
• A functional interaction between the CCR5 and CD34 molecules expressed in hematopoietic cells can support (or even promote) the development of cancer

  2019cites this paper
• Gene-edited babies: What went wrong and what could go wrong

  2019cites this paper
• Recruitment of CD103+ dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy

  2019influential citation
• MDA-9/Syntenin: An emerging global molecular target regulating cancer invasion and metastasis.

  2019cites this paper
• Evaluation of CCR5‐Δ32 mutation among individuals with high risk behaviors, neonates born to HIV‐1 infected mothers, HIV‐1 infected individuals, and healthy people in an Iranian population

  2019cites this paper
• Genetic Polymorphisms in the Open Reading Frame of the CCR5 gene From HIV-1 Seronegative and Seropositive Individuals From National Capital Regions of India

  2019cites this paper
• Optimal design, anti-tumour efficacy and tolerability of anti-CXCR4 antibody drug conjugates

  2019cites this paper
• Cholesterol impacts chemokine CCR5 receptor ligand‐binding activity

  2019cites this paper
• Cytokine CCL5 and Receptor CCR5 Axis in Glioblastoma Multiforme

  2019cites this paper